Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population

European Journal of Human Genetics

Volumn 19, Issue 1, 2011, Pages 64-69

  Wang, Zhi Qiang ^a   Wang, Ning ^a   Van Der Maarel, Silvere ^b   Murong, Shen Xing ^a   Wu, Zhi Ying ^a,c  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINESE; CHROMOSOME 10; CHROMOSOME 4Q; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GENE ASSIGNMENT; GENETIC VARIABILITY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT;

ADOLESCENT; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENETIC VARIATION; HUMANS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PEDIGREE; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERE;

EID: 78650069852     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.143     Document Type: Article

References (23)

1. Padberg GW: Facioscapulohumeral Disease: MD Thesis. Leiden, The Netherlands: Leiden University, 1982.
2. Padgerg GW, Lunt PW, Koch M et al: Facioscapulohumeral muscular dystrophy. In: Emery AEH (ed).: Diagnostic Criteria for Neuromuscular Disorders, 2nd edn. London England: Royal Society of Medicine Press, 1997; 9-16.
3. Wijmenga C, Hewitt JE, Sandkuijl LA et al: Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992; 2: 26-30.
4. Van Deutekom JCT, Wijmenga C, Van Tienhoven EAE et al: FSHD associated DNA rearragements are due to deletions of intergral copies of a 3.2 kb tandemly repeated units. Hum Mol Genet 1993; 2: 2037-2042.
5. Lunt PW: 44th ENMC International Workshop: Facioscapulohumeral Muscular Dystrophy: Molecular Studies 19-21 July 1996, Naarden, The Netherlands. Neuromuscul Disord 1998; 8: 126-130.
6. Lemmers RJ, de Kievit P, Sandkuijl L et al: Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat genet 2002; 32: 235-236.
7. Lemmers RJ, Wohlgemuth M, Frants RR, Padberg GW, Morava E, Van der Maarel SM: Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004; 75: 1124-1130.
8. Thomas NS, Wiseman K, Spurlock G, MacDonald M, Ustek D, Upadhyaya M: A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere. J Med Genet 2007; 44: 215-218.
9. Lemmers RJ, Wohlgemuth M, Van der Gaag KJ et al: Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81: 884-894.
10. Lemmers RJ, Van der Vliet PJ, Van der Gaag KJ et al: Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. Am J Hum Genet 2010; 86: 364-377.
11. Sacconi S, Salviati L, Bourget I et al: Diagnostic challenges in facioscapulohumeral muscular dystrophy. Neurology 2006; 67: 1464-1466.
12. Wu ZY, Wang ZQ, Murong SX, Wang N: FSHD in Chinese population: characteristics of translocation and genotype-phenotype correlation. Neurology 2004; 63: 581-583.
13. Wang ZQ, Wu ZY, Wang N et al: Characteristics of gene structure in FSHD-related 4q35 subtelomere and genotype-phenotype correlation in Chinese Han Population. Zhonghua Yi Xue Za Zhi 2009; 89: 304-310. (in Chinese).
14. Ricci E, Galluzzi G, Deidda G et al: Progress in the molecular diagnosis of faciosca-pulohumeral muscular dystrophy and correlation of the number of KpnI repeats at the 4q35 locus and clinical phenotype. ANN Neurol 1999; 45: 751-757.
15. Lemmers RJ, Osborn M, Haaf T et al: D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology 2003; 61: 178-183.
16. Hack AA, Lam MY, Cordier L et al: Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 2000; 113: 2535-2544.
17. Comerlato EA, Scola RH, Werneck LC: Limb-girdle muscular dystrophy: an immuno-histochemical diagnostic approach. Arq Neuropsiquiatr 2005; 63: 235-245.
18. Felice KJ, North WA, Moore SA, Mathews KD: FSH dystrophy 4q35 deletion in patients presents presenting with facial-sparing scapular myopathy. Neurology 2000; 54: 1927-1931.
19. Krasnianski M, Eger K, Neudecker S, Jakubiczka S, Zierz S: Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Arch Neurol 2003; 60: 1421-1425.
20. Van Der Kooi AJ, Visser MC, Rosenberg N et al: Extension of the clinical range of facioscapulohumeral dystrophy: report of six cases. J Neurol Neurosurg Psychiatry 2000; 69: 114-116.
21. Chen ZJ, Wang ZQ, Wu ZY, Wang N, Lin MT, Murong SX: Analysis of alleles 4qA and 4qB of the chromosome 4q subtelomere in Chinese Han population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24: 334-337. (in Chinese).
22. Auer-Grumbach M, Wagner K, Strasser-Fuchs S et al: Clinical predominance of proximal upper limb weakness in CMT1A syndrome. Muscle Nerve 2000; 23: 1243-1249.
23. Felice KJ, Johns JM, Conway SR: Facioscapulohumeral dystrophy presenting as infantile facial diplegia and limb-girdle myopathy in members of the same family. Muscle Nerve 2005; 32: 368-372.